Stocks · Health care · Surgical & Medical Instruments & Apparatus

GLAUKOS Corp

GKOS Clue Score42
United States Fiscal year ends December CIK 0001192448 Results filed 28 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Gilbert H Kliman
4 Nov 2026
Director
Sold after exercise
2,500
$253.00
$632.50K
Tomas Navratil
30 Oct 2026
Chief Development Officer
Sold after exercise
6,436
$240.52
$1.55M
Tomas Navratil
30 Oct 2026
Chief Development Officer
Sold after exercise
14,943
$239.64
$3.58M
Tomas Navratil
30 Oct 2026
Chief Development Officer
Sold after exercise
12,836
$238.56
$3.06M
Tomas Navratil
30 Oct 2026
Chief Development Officer
Sold after exercise
10,221
$237.54
$2.43M

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 20,233
History held since 30 Jun 2015